|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
423:614-620
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
|
|
A.B.Herr,
E.R.Ballister,
P.J.Bjorkman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Immunoglobulin-alpha (IgA)-bound antigens induce immune effector responses by
activating the IgA-specific receptor FcalphaRI (CD89) on immune cells. Here we
present crystal structures of human FcalphaRI alone and in a complex with the Fc
region of IgA1 (Fcalpha). FcalphaRI has two immunoglobulin-like domains that are
oriented at approximately right angles to each other. Fcalpha resembles the Fcs
of immunoglobulins IgG and IgE, but has differently located interchain
disulphide bonds and external rather than interdomain N-linked carbohydrates.
Unlike 1:1 FcgammaRIII:IgG and Fc epsilon RI:IgE complexes, two FcalphaRI
molecules bind each Fcalpha dimer, one at each Calpha2-Calpha3 junction. The
FcalphaRI-binding site on IgA1 overlaps the reported polymeric immunoglobulin
receptor (pIgR)-binding site, which might explain why secretory IgA cannot
initiate phagocytosis or bind to FcalphaRI-expressing cells in the absence of an
integrin co-receptor.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2: Fc alpha- structure.
a, Ribbon diagrams showing front (left) and side (right)
views of Fc (top)
and Fc (bottom)33.
Disulphide bonds are shown in yellow and carbohydrate residues
are shown in ball-and-stick representation. b, Topology diagram
of Fc .
-Strands
are blue or magenta, 3[10] and -helices
are light blue and disulphides are yellow. The proposed C241
-C241 disulphide bond (not present in our construct) is shown as
a dashed yellow line. Blue and magenta dots show residues that
contact Fc RI.
|
 |
Figure 4.
Figure 4: Fc alpha- RI:Fc
alpha- interface.
Stereoviews of residues at the Fc RI:Fc
interface
(defined as residues with any non-hydrogen atom within 4 Å of
the partner domain). Potential hydrogen bonds are shown as black
dotted lines. Residues are colour-coded according to protein
(a), the chemical character of their side chains (b), or their
effects on binding affinity when substituted^13,14,26 -28 (c).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(2003,
423,
614-620)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.M.Hogarth,
and
G.A.Pietersz
(2012).
Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond.
|
| |
Nat Rev Drug Discov,
11,
311-331.
|
 |
|
|
|
|
 |
C.Papista,
L.Berthelot,
and
R.C.Monteiro
(2011).
Dysfunctions of the Iga system: a common link between intestinal and renal diseases.
|
| |
Cell Mol Immunol,
8,
126-134.
|
 |
|
|
|
|
 |
J.Lu,
K.D.Marjon,
L.L.Marnell,
R.Wang,
C.Mold,
T.W.Du Clos,
and
P.Sun
(2011).
Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein.
|
| |
Proc Natl Acad Sci U S A,
108,
4974-4979.
|
 |
|
|
|
|
 |
A.I.Taylor,
B.J.Sutton,
and
R.A.Calvert
(2010).
Mutations in an avian IgY-Fc fragment reveal the locations of monocyte Fc receptor binding sites.
|
| |
Dev Comp Immunol,
34,
97.
|
 |
|
|
|
|
 |
C.Pilette,
B.Detry,
A.Guisset,
J.Gabriels,
and
Y.Sibille
(2010).
Induction of interleukin-10 expression through Fcalpha receptor in human monocytes and monocyte-derived dendritic cells: role of p38 MAPKinase.
|
| |
Immunol Cell Biol,
88,
486-493.
|
 |
|
|
|
|
 |
D.K.Nayak,
A.Tang,
M.Wilson,
N.W.Miller,
and
E.Bengtén
(2010).
Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4.
|
| |
Mol Immunol,
47,
1306-1316.
|
 |
|
|
|
|
 |
J.H.Davis,
C.Aperlo,
Y.Li,
E.Kurosawa,
Y.Lan,
K.M.Lo,
and
J.S.Huston
(2010).
SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies.
|
| |
Protein Eng Des Sel,
23,
195-202.
|
 |
|
|
|
|
 |
J.Xue,
Q.Zhao,
L.Zhu,
and
W.Zhang
(2010).
Deglycosylation of FcalphaR at N58 increases its binding to IgA.
|
| |
Glycobiology,
20,
905-915.
|
 |
|
|
|
|
 |
M.Duc,
F.E.Johansen,
and
B.Corthésy
(2010).
Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors.
|
| |
J Biol Chem,
285,
953-960.
|
 |
|
|
|
|
 |
R.C.Monteiro
(2010).
Role of IgA and IgA fc receptors in inflammation.
|
| |
J Clin Immunol,
30,
1-9.
|
 |
|
|
|
|
 |
R.C.Monteiro
(2010).
The role of IgA and IgA Fc receptors as anti-inflammatory agents.
|
| |
J Clin Immunol,
30,
S61-S64.
|
 |
|
|
|
|
 |
S.Radaev,
Z.Zou,
P.Tolar,
K.Nguyen,
A.Nguyen,
P.D.Krueger,
N.Stutzman,
S.Pierce,
and
P.D.Sun
(2010).
Structural and functional studies of Igalphabeta and its assembly with the B cell antigen receptor.
|
| |
Structure,
18,
934-943.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.H.Brondijk,
T.de Ruiter,
J.Ballering,
H.Wienk,
R.J.Lebbink,
H.van Ingen,
R.Boelens,
R.W.Farndale,
L.Meyaard,
and
E.G.Huizinga
(2010).
Crystal structure and collagen-binding site of immune inhibitory receptor LAIR-1: unexpected implications for collagen binding by platelet receptor GPVI.
|
| |
Blood,
115,
1364-1373.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Bonner,
A.Almogren,
P.B.Furtado,
M.A.Kerr,
and
S.J.Perkins
(2009).
Location of secretory component on the Fc edge of dimeric IgA1 reveals insight into the role of secretory IgA1 in mucosal immunity.
|
| |
Mucosal Immunol,
2,
74-84.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Bonner,
A.Almogren,
P.B.Furtado,
M.A.Kerr,
and
S.J.Perkins
(2009).
The Nonplanar Secretory IgA2 and Near Planar Secretory IgA1 Solution Structures Rationalize Their Different Mucosal Immune Responses.
|
| |
J Biol Chem,
284,
5077-5087.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Ghumra,
J.Shi,
R.S.Mcintosh,
I.B.Rasmussen,
R.Braathen,
F.E.Johansen,
I.Sandlie,
P.K.Mongini,
T.Areschoug,
G.Lindahl,
M.J.Lewis,
J.M.Woof,
and
R.J.Pleass
(2009).
Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor.
|
| |
Eur J Immunol,
39,
1147-1156.
|
 |
|
|
|
|
 |
A.I.Taylor,
R.L.Beavil,
B.J.Sutton,
and
R.A.Calvert
(2009).
A monomeric chicken IgY receptor binds IgY with 2:1 stoichiometry.
|
| |
J Biol Chem,
284,
24168-24175.
|
 |
|
|
|
|
 |
T.A.Johnson,
J.Qiu,
A.G.Plaut,
and
T.Holyoak
(2009).
Active-site gating regulates substrate selectivity in a chymotrypsin-like serine protease the structure of haemophilus influenzae immunoglobulin A1 protease.
|
| |
J Mol Biol,
389,
559-574.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Qian,
F.Xie,
A.W.Gibson,
J.C.Edberg,
R.P.Kimberly,
and
J.Wu
(2008).
Functional expression of IgA receptor FcalphaRI on human platelets.
|
| |
J Leukoc Biol,
84,
1492-1500.
|
 |
|
|
|
|
 |
M.J.Lewis,
M.Meehan,
P.Owen,
and
J.M.Woof
(2008).
A common theme in interaction of bacterial immunoglobulin-binding proteins with immunoglobulins illustrated in the equine system.
|
| |
J Biol Chem,
283,
17615-17623.
|
 |
|
|
|
|
 |
M.M.Gomes,
S.B.Wall,
K.Takahashi,
J.Novak,
M.B.Renfrow,
and
A.B.Herr
(2008).
Analysis of IgA1 N-glycosylation and its contribution to FcalphaRI binding.
|
| |
Biochemistry,
47,
11285-11299.
|
 |
|
|
|
|
 |
T.I.Arnon,
J.T.Kaiser,
A.P.West,
R.Olson,
R.Diskin,
B.C.Viertlboeck,
T.W.Göbel,
and
P.J.Bjorkman
(2008).
The crystal structure of CHIR-AB1: a primordial avian classical Fc receptor.
|
| |
J Mol Biol,
381,
1012-1024.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Sollazzo,
A.Palmieri,
F.Pezzetti,
A.Scarano,
M.Martinelli,
L.Scapoli,
L.Massari,
G.Brunelli,
E.Caramelli,
and
F.Carinci
(2008).
Genetic effect of anatase on osteoblast-like cells.
|
| |
J Biomed Mater Res B Appl Biomater,
85,
29-36.
|
 |
|
|
|
|
 |
V.Sollazzo,
A.Palmieri,
F.Pezzetti,
C.A.Bignozzi,
R.Argazzi,
L.Massari,
G.Brunelli,
and
F.Carinci
(2008).
Genetic effect of zirconium oxide coating on osteoblast-like cells.
|
| |
J Biomed Mater Res B Appl Biomater,
84,
550-558.
|
 |
|
|
|
|
 |
C.E.Fasching,
T.Grossman,
B.Corthésy,
A.G.Plaut,
J.N.Weiser,
and
E.N.Janoff
(2007).
Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae.
|
| |
Infect Immun,
75,
1801-1810.
|
 |
|
|
|
|
 |
J.L.Stafford,
E.Bengtén,
L.Du Pasquier,
N.W.Miller,
and
M.Wilson
(2007).
Channel catfish leukocyte immune-type receptors contain a putative MHC class I binding site.
|
| |
Immunogenetics,
59,
77-91.
|
 |
|
|
|
|
 |
P.A.Ramsland,
N.Willoughby,
H.M.Trist,
W.Farrugia,
P.M.Hogarth,
J.D.Fraser,
and
B.D.Wines
(2007).
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
|
| |
Proc Natl Acad Sci U S A,
104,
15051-15056.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.D.Wines,
N.Willoughby,
J.D.Fraser,
and
P.M.Hogarth
(2006).
A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA.
|
| |
J Biol Chem,
281,
1389-1393.
|
 |
|
|
|
|
 |
B.D.Wines,
and
P.M.Hogarth
(2006).
IgA receptors in health and disease.
|
| |
Tissue Antigens,
68,
103-114.
|
 |
|
|
|
|
 |
E.R.Sprague,
C.Wang,
D.Baker,
and
P.J.Bjorkman
(2006).
Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.
|
| |
PLoS Biol,
4,
e148.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.M.Woof,
and
M.A.Kerr
(2006).
The function of immunoglobulin A in immunity.
|
| |
J Pathol,
208,
270-282.
|
 |
|
|
|
|
 |
M.M.Gomes,
and
A.B.Herr
(2006).
IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.
|
| |
Springer Semin Immunopathol,
28,
383-395.
|
 |
|
|
|
|
 |
M.Shiroishi,
K.Kuroki,
T.Ose,
L.Rasubala,
I.Shiratori,
H.Arase,
K.Tsumoto,
I.Kumagai,
D.Kohda,
and
K.Maenaka
(2006).
Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer.
|
| |
J Biol Chem,
281,
10439-10447.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Shiroishi,
M.Kajikawa,
K.Kuroki,
T.Ose,
D.Kohda,
and
K.Maenaka
(2006).
Crystal structure of the human monocyte-activating receptor, "Group 2" leukocyte Ig-like receptor A5 (LILRA5/LIR9/ILT11).
|
| |
J Biol Chem,
281,
19536-19544.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Snoeck,
I.R.Peters,
and
E.Cox
(2006).
The IgA system: a comparison of structure and function in different species.
|
| |
Vet Res,
37,
455-467.
|
 |
|
|
|
|
 |
A.Nakamura,
K.Akiyama,
and
T.Takai
(2005).
Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer.
|
| |
Expert Opin Ther Targets,
9,
169-190.
|
 |
|
|
|
|
 |
A.Verdoliva,
D.Marasco,
A.De Capua,
A.Saporito,
P.Bellofiore,
V.Manfredi,
R.Fattorusso,
C.Pedone,
and
M.Ruvo
(2005).
A new ligand for immunoglobulin g subdomains by screening of a synthetic peptide library.
|
| |
Chembiochem,
6,
1242-1253.
|
 |
|
|
|
|
 |
C.S.Kaetzel
(2005).
The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces.
|
| |
Immunol Rev,
206,
83-99.
|
 |
|
|
|
|
 |
H.C.Morton,
R.J.Pleass,
A.K.Storset,
P.Brandtzaeg,
and
J.M.Woof
(2005).
Cloning and characterization of equine CD89 and identification of the CD89 gene in chimpanzees and rhesus macaques.
|
| |
Immunology,
115,
74-84.
|
 |
|
|
|
|
 |
J.M.Woof,
and
J.Mestecky
(2005).
Mucosal immunoglobulins.
|
| |
Immunol Rev,
206,
64-82.
|
 |
|
|
|
|
 |
B.D.Wines,
H.M.Trist,
R.C.Monteiro,
C.Van Kooten,
and
P.M.Hogarth
(2004).
Fc receptor gamma chain residues at the interface of the cytoplasmic and transmembrane domains affect association with FcalphaRI, surface expression, and function.
|
| |
J Biol Chem,
279,
26339-26345.
|
 |
|
|
|
|
 |
E.Quaglino,
S.Rolla,
M.Iezzi,
M.Spadaro,
P.Musiani,
C.De Giovanni,
P.L.Lollini,
S.Lanzardo,
G.Forni,
R.Sanges,
S.Crispi,
P.De Luca,
R.Calogero,
and
F.Cavallo
(2004).
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.
|
| |
J Clin Invest,
113,
709-717.
|
 |
|
|
|
|
 |
E.R.Sprague,
W.L.Martin,
and
P.J.Bjorkman
(2004).
pH dependence and stoichiometry of binding to the Fc region of IgG by the herpes simplex virus Fc receptor gE-gI.
|
| |
J Biol Chem,
279,
14184-14193.
|
 |
|
|
|
|
 |
H.C.Morton,
R.J.Pleass,
J.M.Woof,
and
P.Brandtzaeg
(2004).
Characterization of the ligand binding site of the bovine IgA Fc receptor (bFc alpha R).
|
| |
J Biol Chem,
279,
54018-54022.
|
 |
|
|
|
|
 |
J.M.Woof,
and
D.R.Burton
(2004).
Human antibody-Fc receptor interactions illuminated by crystal structures.
|
| |
Nat Rev Immunol,
4,
89-99.
|
 |
|
|
|
|
 |
K.A.Rogers,
F.Scinicariello,
and
R.Attanasio
(2004).
Identification and characterization of macaque CD89 (immunoglobulin A Fc receptor).
|
| |
Immunology,
113,
178-186.
|
 |
|
|
|
|
 |
P.M.Rudd,
M.R.Wormald,
and
R.A.Dwek
(2004).
Sugar-mediated ligand-receptor interactions in the immune system.
|
| |
Trends Biotechnol,
22,
524-530.
|
 |
|
|
|
|
 |
B.A.Wurzburg,
and
T.S.Jardetzky
(2003).
The IgA receptor complex: a two-for-one deal.
|
| |
Nat Struct Biol,
10,
585-587.
|
 |
|
|
|
|
 |
C.E.Foster,
M.Colonna,
and
P.D.Sun
(2003).
Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors.
|
| |
J Biol Chem,
278,
46081-46086.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |